Please login to the form below

2018: A pivotal year for outsourcing

Managing Director of Ashfield Commercial and Clinical UK, Colin Watson, sat down with Pf Magazine to talk about meeting changing industry demands, new innovations for a new year and why people power is so vital to future success…

A new year’s here, so what can we expect from Ashfield in 2018?

It’s going to be a really exciting year for us. We’ve had a brilliant 2017; we’re the UK market leader for commercial and patient services and we want to keep it that way.

One of the big things on the horizon is the launch of the Salesforce Health Cloud. This will enhance our patient-support programmes by providing a much more personalised, multichannel communication that’ll help patients stay on track with their therapy and get the best outcomes.

We’ll also be expanding our medical information service this year and promoting it to more new clients. I’m delighted with the way this service has grown over the last six years. Clients tell us they love it as a flexible and dependable alternative to in-house teams.

One thing we’re seeing more of is clients asking for more flexibility to switch on and off particular services. The popularity of our syndicated and flex nursing teams is proof of this. I believe the natural next step will be the ability for our clients to pulse activity on a short-term basis. We’re ready to help them with that. 

To read the whole article, please 
click here.

18th January 2018


Company Details


Contact Website

Ashfield House
Resolution Road
Ashby de la Zouch
LE65 1HW

Latest content on this profile

Ashfield wins Best Newcomer at the Pf Awards 2018
We are thrilled to announce that Zuchaela Smylie, from Ashfield, won Best Newcomer at the 2018 Pf Awards, the largest pharmaceutical sales awards in the UK. The awards ceremony took place on Thursday, 9 March at The Lancaster Hotel in London.
“It is evident that meeting face-to-face is still highly valued in the digital age”
Attending a scientific congress or meeting overtakes professional journals and publications as the educational channel of choice for Healthcare Professionals – according to findings of new study
Ashfield to present at the Orphan Drugs for Rare Diseases Summit
Ashfield has a breadth of experience with orphan drugs and we are passionate about helping to improve the lives of people living with rare diseases. We are delighted to be sponsoring and presenting at the ‘Orphan Drugs for Rare Diseases’ event 22-23 March in Berlin.
Addressing the biggest challenges for rare disease communities
Each year, Rare Disease Day takes place worldwide on the last day in February. The main objective of Rare Disease Day is to raise awareness amongst the general public, the healthcare industry and decision-makers about rare diseases and their impact on patients' lives.
Humanise is our strategic approach to healthcare communications. It’s based on the need to understand. It looks at the emotions that make us human. It examines the feelings we have as individuals. It defines the behaviours we show as people.
Ashfield launches new commercial model to improve ROI
Ashfield, part of UDG Healthcare, a global leader in providing outsourced healthcare services, has announced the launch of a pioneering new commercial model called The Ashfield Solution.